Literature DB >> 2809729

Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage.

H Kasuya1, T Shimizu.   

Abstract

The cerebrospinal fluid (CSF) and plasma levels of the complement components C3a and C4a in 40 patients suffering from subarachnoid hemorrhage (SAH) were quantitated by radioimmunoassay. Serial measurements of the lumbar CSF levels revealed that the C3a and C4a levels were significantly elevated in the initial stage of SAH, but decreased rapidly. Within 48 hours after SAH, the mean C3a and C4a levels in the cisternal, lumbar, and ventricular CSF were significantly higher in patients with delayed ischemic neurological deficits (DIND) than in those without DIND. The serially measured plasma levels of C3a and C4a in patients with DIND were elevated more than in those without DIND, but they did not show a significant change over time. Simultaneous levels of fibrinopeptide A (FPA), an indicator of thrombin activity in CSF, were also measured by radioimmunoassay. There was a significant correlation between CSF-activated complement components and CSF FPA. These results suggest that complement activation occurred in the subarachnoid space soon after SAH, chiefly due to activation of the coagulation system. The higher CSF levels of C3a and C4a in patients with DIND may indicate a relationship between these components and the pathogenesis of cerebral vasospasms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809729     DOI: 10.3171/jns.1989.71.5.0741

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 2.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

Review 3.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 4.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

5.  Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage.

Authors:  Silvana Naredi; Gavin Lambert; Peter Friberg; Stefan Zäll; Elisabeth Edén; Bertil Rydenhag; Maria Tylman; Anders Bengtsson
Journal:  Intensive Care Med       Date:  2006-10-13       Impact factor: 17.440

6.  Intranasal administration of E-selectin to induce immunological tolerization can suppress subarachnoid hemorrhage-induced vasospasm implicating immune and inflammatory mechanisms in its genesis.

Authors:  Toshiyuki Nakayama; Kachikwu Illoh; Christl Ruetzler; Sungyoung Auh; Louis Sokoloff; John Hallenbeck
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

7.  Morphometric and ultrastructural analysis of the effect of bromocriptine and cyclosporine on the vasospastic femoral artery of rats.

Authors:  Mehmet Tokmak; Kahan Başocak; Hüseyin Canaz; Gökhan Canaz; Celal İplikçioğlu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 8.  Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review.

Authors:  Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard
Journal:  Biomarkers       Date:  2014-02-05       Impact factor: 2.658

9.  Impaired in vitro proliferative response of suppressor lymphocytes in patients with subarachnoid haemorrhage from ruptured intracranial aneurysm.

Authors:  M Ryba; P Grieb; M Pastuszko; B Wegier-Filipiuk; E Mrowiec; J Andrychowski; L Konopka
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 10.  Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.

Authors:  Joseph R Geraghty; Joseph L Davis; Fernando D Testai
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.